Resveratrol causes antiatherogenic effects in an animal model of atherosclerosis.
Rômulo Dias
RD
Novaes
Maria do Carmo Gouveia
Mdo C
Peluzio
Izabel Regina Dos Santos Costa
IR
Maldonado
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D050197:Atherosclerosis / Q000517:prevention & control*; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D006937:Hypercholesterolemia / Q000378:metabolism*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D013267:Stilbenes / Q000494:pharmacology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002791:Cholesterol, Dietary; D010975:Platelet Aggregation Inhibitors; D013267:Stilbenes